NYSE · traded in Congress
Equifax, EFX
$181.779 -7.811 (-4.12%) Nov 9, 2026 4:05 AM ET
Market value$21.3B
P/E ratio-
Analyst target$200.00
52-week range-
Avg volume762,253
Dividend yield-
Chart
Analyst ratings
- 17 buy
- 11 hold
- 0 sell
Low target$155.00
Average target$199.48
High target$245.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $1,693M | - | $212M | 12.5% | |
| $1,700M | - | $184M | 10.8% | |
| $1,649M | - | $172M | 10.4% | |
| $1,551M | - | $176M | 11.3% |
Congress trades in EFX
Members of Congress disclosed 2 transactions in EFX in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 04/14/2026 | Gilbert Cisneros CA31 | Sale | $1,001 - $15,000 | 5/8/2026 filing |
| 03/13/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
